Use of viral vectors to promote neuroregeneration loost verhaagen

Clinical Neuroscience

Volumn 3, Issue 5, 1995, Pages 275-283

  Gispen, Hendrik ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Adenoviral vector; B 50 GAP 43; Herpes simplex viral vector; Nerve fiber outgrowth; Neuroregeneration; Neurotrophin

Indexed keywords

GROWTH ASSOCIATED PROTEIN; NEUROMODULIN; NEUROTROPHIC FACTOR; NEUROTROPHIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; GENE MUTATION; GENE TARGETING; GENE TRANSFER; HERPES SIMPLEX VIRUS; MOUSE; NERVE CELL LESION; NERVE FIBER GROWTH; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ADENOVIRIDAE; ANIMALS; CENTRAL NERVOUS SYSTEM; GENE THERAPY; GENETIC VECTORS; HUMANS; NERVE REGENERATION; PERIPHERAL NERVOUS SYSTEM; SIMPLEXVIRUS;

EID: 0029548533     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, Brenner H-R, Caroni P (1995): Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83:269-278.
2. Akli S, Caillaud C, Vigne E, StratfordPerricaudet LD, Perricaudet M, Pechanski MR (1993): Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3:224-228.
3. Angelov DM, Neiss WF, Streppel M, Andermahr J, Mader K, Stennert E (1996): Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve. J Neurosci 16:1041-1048.
4. Arena E, Persson H (1994): Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367:368-375.
5. Armentano D, Sookdeo CC, Hehir KM, Gregory RJ, St George JA, Prince GA, Wadsworth SC, Smith AE (1995): Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum Gene Ther 6:1343-1353.
6. Bahr M, Bonhoeffer F (1994): Perspectives on axonal regeneration in the mammalian CNS. TINS 17:473-479.
7. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A (1993): Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 3-229-234
8. Baltleman DS, Geller AI, Chao MV (1993): HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci 13:941-951.
9. Berkner KL (1988): Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616-629.
10. Bregman BS, Kunkel-Bagden E, Schnell L, Ning Dai H, Gao O, Schwab ME (1995): Recovery from spinal injury mediated by antibodies to neurite growth inhibition. Nature 378:498-501.
11. Brodkey JA, Gates MA, Laywell ED, Steindler DA (1993): The complex nature of interactive neuroregeneration-related molecules. Exp Neurol 123:251-270.
12. Byrnes AP, Rusby JE, Wood MJA, Charlton HM (1995): Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024.
13. Caroni P, Schwab ME (1988): Antibody against a myelin-associated inhibitor of neurite growth neurtralizes nonpermissive substrate properties of CNS-white matter. Neuron 1:85-96.
14. David S, Braun PE, Jackson DL, Kottis V, McKerracher L (1995): Laminin overrides the inhibitory effects of PNS and CNS myelin-derived inhibitors of neurite outgrowth. J Neurosci Res 42:594602.
15. Davidson BL, Alien ED, Kozarsky KF, Wilson JM, Roessler BJ (1993): A model system for in vivo gene transfer into the CNS using an adenoviral vector. Nat Genet 3:219-223.
16. Doster SK, Lozano AM, Aguano AJ, Willard WB (1991): Expression of the growthassociated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron 6:635-647.
17. Engelhardt JF, Ye X, Doranz B, Wilson JM (1994) Ablation of E2a in recombinant adenoviruses improves transgene expression and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91:6196-6200.
18. Federoff HJ, Geschwind MG, Geller AI, Kessler JA (1992): Expression of nerve growth factor in vivo from a defective herpes simplex virus prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA 89:1636-1640.
19. Finiels F, Gimenez y Ribotta M, Barkats M, Samolyk M, Robert J, Privat A, Revah F, Mallet J (1995): Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuroreport 7:373378.
20. Fisher KJ, Choi H, Burda J, Chen S, Wilson J (1996) Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11-22.
21. Frenkel N (ed) (1981): Defective interfering herpes viruses. In: The Human Herpes Viruses: An Interdisciplinary Prospective. New York: Elsevier-North Holland, Inc.
22. Geller AI, Breakefield XO (1988): A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241:1667-1669.
23. Geschwind MD, Lu B, Federoff HJ (1994): Viral transfection of intrinsic cells within the brain. Expression of neurotrophic genes from HSV-1 vectors: Modifying neuronal phenotype. In P Conn (ed): Providing Pharmacological Access to the Brain. Methods Neurosci, vol. 21. New York: Academic Press, Inc., pp 462-482.
24. Geschwind MD, Hartnick CJ, Liu W, Amat J, Van de Water TR, Federoff HJ (1996): Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: Model for treatment of neuron loss following cochlear degeneration. Human Gene Ther 7:173-182.
25. Giger RJ, Pasterkamp RJ, Verhaagen J (1996): Ectopic adenoviral vector directed expression of semaphorin III/ Collapsin-1 in neuronal explants repels growing axons of primary sensory neurons. Experientia 52.
26. Glasby MA, Hems TEJ (1995): Repairing spinal roots after brachial plexus injuries. Paraplegia 33:359-361.
27. Hefti F (1994): Neurotrophic factor therapy for nervous system degenerative disease. J Neurobiol 25:1418-1435.
28. Hermens WTJMC, Giger RJ, Holtmaat AJGD, Dijkhuizen PA, Houweling D, Verhaagen J (1996): Transient gene transfer to neurons and glia: Analysis of adenoviral vector performance in the CNS and PNS. J Neurosci Methods (in press).
29. Hodgson CP (1995): The vector void in gene therapy. Can viral vectors and transfection be combined to permit safe, efficacious, and targeted gene therapy? BioTechnology 13:222-225.
30. Holtmaat AJGD, Dijkhuizen PA, Oestreicher AB, Romijn HJ, Van der Lugt NMT, Berns A, Margolis FL, Gispen WH, Verhaagen J (1995): Directed expression of the growth-associated protein B-50/ GAP-43 to olfactory neurons in trans-genie mice results in changes in axon morphology and extraglomerular fiber growth. J Neurosci 15:7953-7965.
31. Holtmaat AJGD, Hermens YVTJMC, Oestreicher AB, Gispen WH, Kaplitt MG, Verhaagen J (1996a): Efficient adenoviral vector-directed expression of a foreign gene to neurons and sustentacular cells in the mouse olfactory neuroepithelium. Mol Brain Res (in press).
32. Holtmaat AJGD, Hermens VVTJMC, Sonnemans MAP, Van Leeuwen FVV, Kaplitt MG, Oestreicher AB, Gispen WH, Verhaagen J (1996b): Adenoviral vector mediated expression of B-50/GAP-43 induces alterations in the membrane organization of olfactory axon terminals in-vivo. Abstr Soc Neurosci (in press).
33. Johnson H, Hökfelt T, Ulfhake B (1996): Decreased expression of trkB and trkC mRNA in spinal motor neurons of aged rats. Eur J Neurosci 8:494-499.
34. Kaplitt MG, Pfaus JG, Kleopoulos SP, Hanlon BA, Rabkin SD, Pfaff DVV (1991): Expression of a functional foreign gene in adult mammalian brain following in vitro transfer via a Herpes Simplex virus Type 1 defective vector. Mol Cell Neurosci 2:320-330.
35. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994): Long-term gene expression and phenotypic correction using adenoassociated virus vectors in the mammalian brain. Nat Genet 8:148-154.
36. Kay MA, Holterman AX, Meuse L, Gown A, Ochs HD, Linsley PS, Wilson CB (1995) Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet 11:191-197.
37. Kline DG (1990): Surgical repair of peripheral nerve injury. Muscle Nerve 13:843853.
38. Kolodkin AL (1996): Semaphorins: Mediators of repulsive growth cone guidance. Cell Biol 6:15-22.
39. Kordower JH, Winn SR, Liu Y-T, Mufson EJ, Sladek JR, Hammang JP, Edward Baetge E, Emerich DF (1994): The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91:1089810902.
40. Le Gai La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J (1993): An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
41. Leib DA, Oliva PD (1993): Gene delivery to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15:547554.
42. Lewin GR, Barde Y-A (1996): Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
43. Lochmüller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G, Acsadi G (1994): Emergence of early region 1-containing replication-competent adenovirus in stocks of replicationdefective adenovirus recombinants (dEl + dE3) during passages in 293 cells. Hum Gene Ther 5:1485-1491.
44. Luo Y, Raible D, Râper JA (1993): Collapsin: A protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217-227.
45. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo A] (1994): Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 91:1632-1636.
46. McCown TJ, Xiax X, Li J, Breese GR, Samulski RS (1996): Differential and persistent expression patterns of CNS gene transfer by an adeno-associated viral (AW) vector. Brain Res 713:99107.
47. Nicholls J, Saunders N (1996): Regeneration of immature mammalian spinal cord after injury. TINS 19:229-234.
48. Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF (1996): Colocalization of high-affinity neurotrophin receptors in Nucleus Basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience (in press).
49. Schnell L, Schwab ME (1990): Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neunte growth inhibitions. Nature 343:269-272.
50. Schnell L, Schneider R, Kolbeck R, Barde Y-A, Schwab ME (1994): Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 367:170-173.
51. Skene JHP, VVillard M (1981): Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous system. J Cell Biol 89:96-103.
52. Strand FL, Rose KL, Zuccarelli LA, Kume J, Alves SE, Antonawich FJ, Garrett LY (1991): Neuropeptide hormones as neurotrophic factors. Physiol Rev 71:10171046.
53. Tessier-Lavigne M (1995): Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps. Cell 82:345-348.
54. Tetzlaff W, Zwiers H, Lederis K, Cassar L, Bisby MA (1989): Axonal transport and localization of B-50/GAP-43-like immunoreactivity in regenerating sciatic and facial nerves. J Neurosci 9:1303-1313.
55. Tetzlaff W, Tsui B, Balfeur JK (1990): Rubrospinal neurons increase GAP-43 and tubulin mRNA after cervical but not after thoracic axotomy. Soc Neurosci Abstr 16:338.
56. Tetzlaff W, Alexander BW, Miller FD, Bisby MA (1991): Response of facial and rubrospinal neurons to axotomy: Changes in mRNA expression for cytoskeletal proteins and GAP-43. J Neurosci 11:2528-2544.
57. Vaudano E, Campbell G, Anderson PN, Davies AP, Woolhead C, Schreyer DJ, Lieberman AR (1995): The effects of a lesion or a peripheral nerve graft on GAP-43 upregulation in the adult rat brain: An in situ hybridization and immunocytochemical study. J Neurosci 15:3594-3611.
58. Verhaagen J, Van Hooff COM, Edwards PM, De Graan PNE, Oestreicher AB, Jennekens FGL, Gispen WH (1986): The kinase C substrate protein B-50 and axonal regeneration. Brain Res Bull 17:737-741.
59. Verhaagen J, Oestreicher AB, Edwards PM, Veldman H, Jennekens FGI, Gispen WH (1988): Light and electron microscopical study of phosphoprotein B-50 following denervation and reinnervation of the rat soleus muscle. J Neurosci 8:1759-1766.
60. Verhaagen J, Zhang Y, Hamers FPT, Gispen WH (1993): Elevated expression of B-50(GAP-43)mRNA in a subpopulation of olfactory bulb mitral cells following axotomy. J Neurosci Res 35:162-169.
61. Verhaagen J, Hermens VVTJMC, Oestreicher AB, Gispen WH, Rabkin SD, Pfaff DW, Kaplitt MG (1994): Expression of the growth-associated protein B-50/ GAP-43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells. Mol Brain Res 26:26-36.
62. Verhaagen J, Hermens WTJMC, Holtmaat AJGD, Oestreicher AB, Gispen WH, Kaplitt MG (1995): Viral vector-mediated gene transfer in the nervous system: Application to the reconstruc-lion of neural circuits in the injured mammalian brain. In Kaplitt MG, Loewy AD (eds): Viral Vectors. New York: Academic Press, pp 119-132.
63. Vilquin JT, Guerette B, Kinoshita I, Roy B, Goulet M, Gravel C, Roy R, Tremblay JP (1995) FK506 Immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther 6:1391-1401.
64. Wang MJ, Friedmann T, Johnson PA (1995): Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor. Gene Therapy 2:323-335.
65. Widmer F, Caroni P (1993): Phosphorylation-site mutagenesis of the growthassociated protein GAP-43 modulates its effect on cell spreading and morphology. J Cell Biol 120:503-512.
66. Winkler J, Thal LJ (1994): Clinical potential of growth factors in neurological disorders. CNS Drugs 2:465-478.
67. Wood MJA, Byrnes AP, Pfaff DW, Rabkin SO, Charlton HM (1994): Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Therapy 1:283-291.
68. Xu H, Federoff H, Maragos J, Parada LF, Kessler JA (1994): Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev Biol 163:152-161.
69. Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM (1994) Inactivation of E2a in recombinant adenoviruses limits cellular immunity and improves the prospect for gene therapy of cystic fibrosis. Nat Genet 7:362-369.
70. Yang Y, Li Q, Ertl HC, Wilson JM (1995a) Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 2004-2015.
71. Yeh P, Dedieu ], Orsini S, Vigne E, Denefle P, Perricaudet M (1996) Efficient dual transcomplementation of edenovirus El and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 70(l):559-565.
72. Zuber MX, Goodman DW, Karns LR, Fishman MC (1989): The neuronal growth-associated protein GAP-43 induces filopodia in non-neuronal cells. Science 244:1193-1195.